CFTR gene mutations in pancreatitis: Frequency and clinical manifestations in an Austrian patient cohort

Wiener Klinische Wochenschrift

Volumn 119, Issue 17-18, 2007, Pages 527-533

  Zoller, Heinz ^a   Egg, Margit ^a,b   Graziadei, Ivo ^a   Creus, Marc ^a   Janecke, Andreas R ^a   Löffler Ragg, Judith ^a   Vogel, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cystic fibrosis transmembrane conductance regulator; Genetic screening; Pancreatitis

Indexed keywords

ACUTE PANCREATITIS; ADULT; ARTICLE; AUSTRIA; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS TRANSMEMBRANE REGULATOR GENE; DISEASE CLASSIFICATION; DISEASE COURSE; EUROPE; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HETEROZYGOTE; HUMAN; IDIOPATHIC DEFINITIVE CHRONIC PANCREATITIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLEX POLYMERASE CHAIN REACTION; PANCREATITIS; RISK FACTOR;

AUSTRIA; COHORT STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATITIS, CHRONIC; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 35548940355     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0849-5     Document Type: Article

References (33)

1. Strate T, Knoefel WT, Yekebas E, Izbicki JR (2003) Chronic pancreatitis: etiology, pathogenesis, diagnosis, and treatment. Int J Colorectal Dis 18: 97-106
2. Clain JE, Pearson RK (1999) Diagnosis of chronic pancreatitis. Is a gold standard necessary? Surg Clin North Am 79: 829-845
3. Lankisch PG (2001) Natural course of chronic pancreatitis. Pancreatology 1: 3-14
4. Otsuki M, Nishimori I, Hayakawa T, Hirota M, Ogawa M, Shimosegawa T (2004) Hereditary pancreatitis: clinical characteristics and diagnostic criteria in Japan. Pancreas 28: 200-206
5. Etemad B, Whitcomb DC (2001) Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 120: 682-707
6. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK, Jr., Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14: 141-145
7. Simon P, Weiss FU, Sahin-Toth M, Parry M, Nayler O, Lenfers B, Schnekenburger J, Mayerle J, Domschke W, Lerch MM (2002) Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 → Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 277: 5404-5410
8. Chen JM, Mercier B, Audrezet MP, Raguenes O, Quere I, Ferec C (2001) Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 120: 1061-1064
9. Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, Furey WF, Whitcomb DC (2000) SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119: 615-623
10. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25: 213-216
11. Bhatia E, Balasubramanium K, Rajeswari J, Kordonouri O, Witt H, Landt O, Simon P, Lerch MM (2003) Absence of association between SPINK1 trypsin inhibitor mutations and Type 1 or 2 diabetes mellitus in India and Germany. Diabetologia 46: 1710-1711
12. Weiss FU, Simon P, Witt H, Mayerle J, Hlouschek V, Zimmer KP, Schnekenburger J, Domschke W, Neoptolemos JP, Lerch MM (2003) SPINK1 mutations and phenotypic expression in patients with pancreatitis associated with trypsinogen mutations. J Med Genet 40: e40
13. Weiss FU, Simon P, Bogdanova N, Mayerle J, Dworniczak B, Horst J, Lerch MM (2005) Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. Gut 54: 1456-1460
14. Bernardino AL, Guarita DR, Mott CB, Pedroso MR, Machado MC, Laudanna AA, Tani CM, Almeida FL, Zatz M (2003) CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients. Jop 4: 169-177
15. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339: 653-638
16. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339: 645-652
17. Ockenga J, Stuhrmann M, Ballmann M, Teich N, Keim V, Dork T, Manns MP (2000) Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 95: 2061-2067
18. Choudari CP, Imperiale TF, Sherman S, Fogel E, Lehman GA (2004) Risk of pancreatitis with mutation of the cystic fibrosis gene. Am J Gastroenterol 99: 1358-1363
19. Gelrud A, Sheth S, Banerjee S, Weed D, Shea J, Chuttani R, Howell DA, Telford JJ, Carr-Locke DL, Regan MM, Ellis L, Durie PR, Freedman SD (2004) Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol 99: 1557-1562
20. Casals T, Aparisi L, Martinez-Costa C, Gimenez J, Ramos MD, Mora J, Diaz J, Boadas J, Estivill X, Farre A (2004) Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 28: 374-379
21. Estivill X, Bancells C, Ramos C (1997) Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. Hum Mutat 10: 135-154
22. Stuhrmann M, Dork T, Fruhwirth M, Golla A, Skawran B, Antonin W, Ebhardt M, Loos A, Ellemunter H, Schmidtke J (1997) Detection of 100% of the CFTR mutations in 63 CF families from Tyrol. Clin Genet 52: 240-246
23. Bobadilla JL, Macek M Jr, Fine JP, Farrell PM (2002) Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum Mutat 19: 575-606
24. Homma T, Harada H, Koizumi M (1997) Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society. Pancreas 15: 14-15
25. de Vries HG, Collee JM, de Walle HE, van Veldhuizen MH, Smit Sibinga CT, Scheffer H, ten Kate LP (1997) Prevalence of delta F508 cystic fibrosis carriers in The Netherlands: logistic regression on sex, age, region of residence and number of offspring. Hum Genet 99: 74-79
26. Castellani C, Quinzii C, Altieri S, Mastella G, Assael BM (2001) A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes. Genet Test 5: 249-254
27. Ammann RW (1997) A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas 14: 215-221
28. Turcios NL (2005) Cystic fibrosis: an overview. J Clin Gastroenterol 39: 307-317
29. Ribeiro CM, Paradiso AM, Carew MA, Shears SB, Boucher RC (2005) Cystic fibrosis airway epithelial Ca2+ i signaling: the mechanism for the larger agonist-mediated Ca2+ i signals in human cystic fibrosis airway epithelia. J Biol Chem 280: 10202-10209
30. Egan ME, Glockner-Pagel J, Ambrose C, Cahill PA, Pappoe L, Balamuth N, Cho E, Canny S, Wagner CA, Geibel J, Caplan MJ (2002) Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med 8: 485-492
31. De Boeck K, Weren M, Proesmans M, Kerem E (2005) Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics 115: e463-e469
32. Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 3: 151-156
33. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC, Ruiz-Romero J, Verlingue C, Claustres M, et al (1995) Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332: 1475-1480